Pennies in Action® was founded in 2007 by Uschi Keszler – Olympic athlete, Olympic coach, and double cancer survivor. Having survived and seen the conquering of tuberculosis in her youth, and now as a survivor of both breast and uterine cancer, Uschi is determined to see cancer beaten in her lifetime too.
As an elite athlete, Uschi is very aware of the power and resiliency of the human body. So when she decided to help find a way to beat cancer, she knew that she could not support something that would destroy the body in order to heal it. Finding out that her surgeon was already in clinical trials of a vaccine that utilizes the patient’s own immune system to fight breast cancer, she knew she had found her first project.
Dr. Brian Czerniecki’s research aligned perfectly with Uschi’s goals and her philosophy.Pennies in Action is about more than just raising funds for cancer research – Uschi has a strong belief that everyone, young and old, rich and poor, those with health insurance, and those without, can have ownership in the research. One does not have to be wealthy to have an impact.
The amount one person may give may be relatively small – for a penny alone has little value – but many pennies make many dollars. The power to make a difference can come from just a few pennies if many people take part in even a small way.
USCHI KESZLER is an Olympic athlete and coach, and double cancer survivor. Having survived TB in her youth, and more recently survived both breast and uterine cancer, Uschi is determined to see cancer cured in her lifetime. She founded Pennies in Action® in 2007 and has been instrumental in raising funds for Dr. Brian Czerniecki’s breakthrough vaccine.
BRIAN J. CZERNIECKI, MD, PhD is the Rhodes-Harrington Professor in Surgical Oncology at the University of Pennsylvania and the Co-Director of the Rena Rowan Breast Center. His research interests focus on dendritic cell biology and interactions with T cells. He has developed dendritic cell vaccines for the treatment of cancer and is involved with several clinical trials for treating patients with early breast cancer with dendritic cell vaccines.
The overall goal is develop vaccines for the prevention of breast cancer and other solid tumors. He is identifying molecular targets in early breast cancer that can be used for prevention of invasion and metastasis.Dr. Czerniecki received his BS in Biochemistry from the University of Maine and MD, PhD from UMDNJ-Robert Wood Johnson and Rutgers University. He completed his general surgical residency at The Ohio State University and was Surgical Oncology Fellow at the NCI with Dr. Steven Rosenberg prior to his position at the University of Pennsylvania.
Read More Dr. Czerniecki 's Articles Published in various Medical Journals
Imagine a life without cancer. Over 90 cents of every dollar goes to patients & research.